Indian scientists on Monday announced launching an ambitious project to develop a pan-coronavirus vaccine that would give protection not only against known infections like MERS, SARS and Covid-19 but also from any other coronavirus infections that may emerge in the future.
With funding support of $12.5 million (over Rs 93 crore) from a global agency, scientists from Translational Health, Science and Technology Institution, Faridabad and Panacea Biotech will work together to come out with such a vaccine.
The aim would be to develop a broadly protective beta-coronavirus vaccine effective against multiple types of coronaviruses including MERS, SARS and Covid-19, Syed Khalid Ali, project leader at Panacea Biotech said at a press conference.
Discussion about this post